{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T05:42:00Z","timestamp":1745214120729,"version":"3.40.3"},"reference-count":29,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,4,1]]},"DOI":"10.2169\/internalmedicine.3872-24","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T22:11:36Z","timestamp":1726006296000},"page":"1061-1065","source":"Crossref","is-referenced-by-count":2,"title":["Exacerbation of Thyroid Eye Disease and Dysthyroid Optic Neuropathy during Pregnancy"],"prefix":"10.2169","volume":"64","author":[{"given":"Masakazu","family":"Koshibu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuko","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nami","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyoshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Onda","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Kozaki","sequence":"additional","affiliation":[{"name":"Olympia Eye Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigenori","family":"Hiruma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Sankoda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Fukushita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Yoshihara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeduk","family":"Yoshimura Noh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Sugino","sequence":"additional","affiliation":[{"name":"Department of Surgery, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Surgery, Ito Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hiromatsu Y, Eguchi H, Tani J, Kasaoka M, Teshima Y. Graves' ophthalmopathy: epidemiology and natural history. Intern Med 53: 353-360, 2014.","DOI":"10.2169\/internalmedicine.53.1518"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bartalena L, Tanda ML. Graves' ophthalmopathy. N Engl J Med 360: 994-1001, 2009.","DOI":"10.1056\/NEJMcp0806317"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Guller S, Kong L, Wozniak R, Lockwood CJ. Reduction of extracellular matrix protein expression in human amnion epithelial cells by glucocorticoids: a potential role in preterm rupture of the fetal membranes. J Clin Endocrinol Metab 80: 2244-2250, 1995.","DOI":"10.1210\/jcem.80.7.7608287"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lockwood CJ, Radunovic N, Nastic D, Petkovic S, Aigner S, Berkowitz GS. Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy. J Perinat Med 24: 243-251, 1996.","DOI":"10.1515\/jpme.1996.24.3.243"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. \u00d8stensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8: 209, 2006.","DOI":"10.1186\/ar1957"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Burch HB, Perros P, Bednarczuk T, et al. Management of thyroid eye disease: a consensus statement by the American Thyroid Association and the European Thyroid Association. Thyroid 32: 1439-1470, 2022.","DOI":"10.1089\/thy.2022.0251"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lucarelli MJ, Shore JW. Management of thyroid optic neuropathy. Int Ophthalmol Clin 36: 179-193, 1996.","DOI":"10.1097\/00004397-199603610-00018"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Guy JR, Fagien S, Donovan JP, Rubin ML. Methylprednisolone pulse therapy in severe dysthyroid optic neuropathy. Ophthalmology 96: 1048-1052; discussion 52-53, 1989.","DOI":"10.1016\/S0161-6420(89)32784-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wakelkamp IM, Baldeschi L, Saeed P, Prummel MF, Wiersinga WM. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial. Clin Endocrinol 63: 323-328, 2005.","DOI":"10.1111\/j.1365-2265.2005.02345.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Milligan NM, Newcombe R, Compston DA. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry 50: 511-516, 1987.","DOI":"10.1136\/jnnp.50.5.511"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Kazim M, Trokel S, Moore S. Treatment of acute Graves' orbitopathy. Ophthalmology 98: 1443-1448, 1991.","DOI":"10.1016\/S0161-6420(91)32114-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gold KG, Scofield S, Isaacson SR, Stewart MW, Kazim M. Orbital radiotherapy combined with corticosteroid treatment for thyroid eye disease-compressive optic neuropathy. Ophthalmic Plast Reconstr Surg 34: 172-177, 2018.","DOI":"10.1097\/IOP.0000000000001003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wall JR, Lahooti H, Hibbert EJ, Champion B. Relationship between clinical and immunological features of thyroid autoimmunity and ophthalmopathy during pregnancy. J Thyroid Res 698470, 2015.","DOI":"10.1155\/2015\/698470"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Jang SY, Shin DY, Lee EJ, Lee SY, Yoon JS. Relevance of TSH-receptor antibody levels in predicting disease course in Graves' orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay. Eye 27: 964-971, 2013.","DOI":"10.1038\/eye.2013.120"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Eckstein AK, Plicht M, Lax H, et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 91: 3464-3470, 2006.","DOI":"10.1210\/jc.2005-2813"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Watanabe N, Yoshimura Noh J, Kozaki A, et al. Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal of a predictive score. Endocr J 70: 1087-1096, 2023.","DOI":"10.1507\/endocrj.EJ23-0079"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wiersinga W, \u017darkovi\u0107 M, Bartalena L, et al.; EUGOGO (Europian Group on Graves' Orbitopathy). Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism. Eur J Endocrinol 178: 635-643, 2018.","DOI":"10.1530\/EJE-18-0039"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ahn HY, Lee J, Lee JK. Predictive model for Graves' ophthalmopathy in patients with new-onset Graves' disease. Thyroid 32: 1559-1567, 2022.","DOI":"10.1089\/thy.2022.0280"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K. Thyroid-stimulating antibody is related to Graves' ophthalmopathy but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Thyroid 10: 809-813, 2000.","DOI":"10.1089\/thy.2000.10.809"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tabasum A, Khan I, Taylor P, Das G, Okosieme OE. Thyroid antibody-negative euthyroid Graves' ophthalmopathy. Endocrinol Diabetes Metab Case Rep 2016: 160008, 2016.","DOI":"10.1530\/EDM-16-0008"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Douglas RS, Gianoukakis AG, Kamat S, Smith TJ. Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis. J Immunol 178: 3281-3287, 2007.","DOI":"10.4049\/jimmunol.178.5.3281"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Smith TJ, Kahaly GJ, Ezra DG, et al. Teprotumumab for thyroid-associated ophthalmopathy. N Engl J Med 376: 1748-1761, 2017.","DOI":"10.1056\/NEJMoa1614949"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Douglas RS, Kahaly GJ, Patel A, et al. Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med 382: 341-352, 2020.","DOI":"10.1056\/NEJMoa1910434"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Senoo J, Morikawa H, Mochizuki M, Ueda Y. Maternal nutritional states and serum insulin-like growth factor-I (IGF-I) concentrations in normal and abnormal pregnancy. Nihon Naibunpi Gakkai Zasshi (Folia Endocrinol Jpn) 70: 597-608, 1994 (In Japanese).","DOI":"10.1507\/endocrine1927.70.6_597"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML. Epidemiology, natural history, risk factors, and prevention of Graves' orbitopathy. Front Endocrinol 11: 615993, 2020.","DOI":"10.3389\/fendo.2020.615993"},{"key":"26","unstructured":"26. Lippi G, Albiero A, Montagnana M, et al. Lipid and lipoprotein profile in physiological pregnancy. Clin Lab 53: 173-177, 2007."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Alvarez JJ, Montelongo A, Iglesias A, Lasunci\u00f3n MA, Herrera E. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res 37: 299-308, 1996.","DOI":"10.1016\/S0022-2275(20)37617-3"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hussain T, Murtaza G, Metwally E, et al. The role of oxidative stress and antioxidant balance in pregnancy. Mediators Inflamm 2021: 9962860, 2021.","DOI":"10.1155\/2021\/9962860"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Aranyosi JK, Deli T, Erdei A, et al. Unusual onset of thyroid associated orbitopathy during pregnancy: case report and review of literature. BMC Endocr Disord 20: 183, 2020.","DOI":"10.1186\/s12902-020-00663-9"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/7\/64_3872-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T03:46:23Z","timestamp":1743824783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/7\/64_3872-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3872-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"article-number":"3872-24"}}